Elizabeth Blackburn

First Person | Elizabeth Blackburn Photo: © UCSF News Office One day, when Elizabeth Blackburn was about 15, mischief filled her mind. She and a friend mixed ammonia and iodine, then watched as their fellow French-language classmates reacted to the bang. "I was a bad girl," recounts Blackburn, known worldwide for her work on telomeres, the structures that stabilize the ends of eukaryotic chromosomes. What's on her mind today is deciphering how the enzyme telomerase works, as it is cr

| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

One day, when Elizabeth Blackburn was about 15, mischief filled her mind. She and a friend mixed ammonia and iodine, then watched as their fellow French-language classmates reacted to the bang. "I was a bad girl," recounts Blackburn, known worldwide for her work on telomeres, the structures that stabilize the ends of eukaryotic chromosomes.

What's on her mind today is deciphering how the enzyme telomerase works, as it is critical to unrestricted cell growth. A cell and molecular biologist and professor at the University of California, San Francisco, Blackburn, 53, has earned numerous accolades and scientific academy memberships, including the National Academy of Sciences.

Married to life scientist John Sedat, whom she met while at Cambridge University, Blackburn says her passion for biology emerged during her teenage years--the French class escapade not withstanding--and still consumes her. "I haven't grown up," she says, in her gentle native Australian accent. "I love ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies